TTRX
TTRX
NASDAQ · Pharmaceuticals

Turn Therapeutics Inc

$9.35
+0.41 (+4.59%)
As of Nov 7, 2:26 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 1 11%
Sell 1 11%
Price in Context
52-Week High
$16.45
-43.2% from high
52-Week Low
$2.57
+263.8% from low
Next Earnings Report
Nov 12, 2026
4d
until earnings
EPS Est: $-0.09
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%